Lauffer LM - Search Results

1

Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.

Kühnen P, Matthae R, Arya V, Hauptmann K, Rothe K, Wächter S, Singer M, Mohnike W, Eberhard T, Raile K, Lauffer LM, Iakoubov R, Hussain K, Blankenstein O. Kühnen P, et al. Among authors: lauffer lm. Clin Endocrinol (Oxf). 2014 Dec;81(6):847-54. doi: 10.1111/cen.12473. Epub 2014 May 19. Clin Endocrinol (Oxf). 2014. PMID: 24750227

2

Essential role for protein kinase Cζ in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat.

Iakoubov R, Ahmed A, Lauffer LM, Bazinet RP, Brubaker PL. Iakoubov R, et al. Among authors: lauffer lm. Endocrinology. 2011 Apr;152(4):1244-52. doi: 10.1210/en.2010-1352. Epub 2011 Feb 15. Endocrinology. 2011. PMID: 21325047

3

T1R3: how to indulge the gut's sweet tooth.

Iakoubov R, Lauffer LM. Iakoubov R, et al. Among authors: lauffer lm. Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E813-4. doi: 10.1152/ajpendo.00418.2012. Epub 2012 Aug 14. Am J Physiol Endocrinol Metab. 2012. PMID: 22895784 Free article. No abstract available.

4

GPR119: "double-dipping" for better glycemic control.

Lauffer L, Iakoubov R, Brubaker PL. Lauffer L, et al. Endocrinology. 2008 May;149(5):2035-7. doi: 10.1210/en.2008-0182. Endocrinology. 2008. PMID: 18427153 No abstract available.

5

Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice.

Iakoubov R, Lauffer LM, Trivedi S, Kim YI, Brubaker PL. Iakoubov R, et al. Among authors: lauffer lm. Endocrinology. 2009 Sep;150(9):4033-43. doi: 10.1210/en.2009-0295. Epub 2009 Jun 4. Endocrinology. 2009. PMID: 19497974

6

Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.

Sangle GV, Lauffer LM, Grieco A, Trivedi S, Iakoubov R, Brubaker PL. Sangle GV, et al. Among authors: lauffer lm. Endocrinology. 2012 Feb;153(2):564-73. doi: 10.1210/en.2011-1732. Epub 2011 Dec 20. Endocrinology. 2012. PMID: 22186413

7

GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.

Lauffer LM, Iakoubov R, Brubaker PL. Lauffer LM, et al. Diabetes. 2009 May;58(5):1058-66. doi: 10.2337/db08-1237. Epub 2009 Feb 10. Diabetes. 2009. PMID: 19208912 Free PMC article.

8

Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell.

Mulherin AJ, Oh AH, Kim H, Grieco A, Lauffer LM, Brubaker PL. Mulherin AJ, et al. Among authors: lauffer lm. Endocrinology. 2011 Dec;152(12):4610-9. doi: 10.1210/en.2011-1485. Epub 2011 Oct 4. Endocrinology. 2011. PMID: 21971158

9

Evidence for a two-step mechanism involved in assembly of functional signal recognition particle receptor.

Andrews DW, Lauffer L, Walter P, Lingappa VR. Andrews DW, et al. J Cell Biol. 1989 Mar;108(3):797-810. doi: 10.1083/jcb.108.3.797. J Cell Biol. 1989. PMID: 2537835 Free PMC article.

10

The signal recognition particle receptor is a complex that contains two distinct polypeptide chains.

Tajima S, Lauffer L, Rath VL, Walter P. Tajima S, et al. J Cell Biol. 1986 Oct;103(4):1167-78. doi: 10.1083/jcb.103.4.1167. J Cell Biol. 1986. PMID: 3021779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page